- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Jeffrey S. Spigel (Jeff)
News 31 results
In the News · Source: Global Legal Chronicle
September 8, 2023
K&S advises Mativ on the $620M proposed sale of its Engineered Papers business to Evergreen Hill Enterprise
In the News · Source: Law360, The Deal and Law.com
Cases & Deals
August 1, 2023
Mativ Holdings Announces Proposed Sale of its Engineered Papers Business for $620 Million
In the News · Source: Law360, The American Lawyer, The Deal and Bloomberg Law
Events 6 results
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Conference
March 20, 2023
32nd Annual King & Spalding Health Law & Policy Forum
Conference
November 1, 2022
Pharmaceutical University 2022
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Insights 38 results
Client Alert
September 25, 2023
FTC Enforcement Action Against USAP
Client Alert
August 23, 2023
FTC and DOJ Announce New Enforcement Actions Against Interlocking Directorates
Client Alert
August 14, 2023
FTC and DOJ Announce New Draft Merger Guidelines
Client Alert
July 10, 2023
FTC and DOJ jointly announced proposed changes to the HSR premerger notification form